September 2019

Clinical Viewpoint

September 29, 2020

Despite early reservations, available literature suggests that it may be time to invest in the utilization of wellness-based methods in the treatment of migraine.

Clinical Viewpoint

September 29, 2020

New classes of acute migraine therapies on the cusp of FDA approval look to fill in long-standing gaps in care.

After a long period of time with minimally effective treatments for migraine, the growing understanding of the CGRP pathway has opened the door to a variety of new and highly efficacious therapies for patients with chronic and episodic forms of disease.

Clinical Viewpoint

September 29, 2020

Reproductive considerations and hormonal fluctuations throughout a woman’s life require careful consideration when treating migraine.

Clinical Viewpoint

September 29, 2020

Reducing the frequency of migraine is only 1 step in the process of optimizing management and addressing the disease's impact on patients’ lives.